Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Human Creation, Oct-Dec (1Q) Ordinary Profit Increases by 53%
7361 Human Creation Holdings, Inc. 【J-GAAP】
Earnings ReportHuman Creation Holdings, Inc. <7361> [TSE Growth] announced its financial results after the market closed on February 10th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending September 2025 (October to December) expanded 212 million yen, an increase 52.5% compared to the same period last year. The progress rate toward the full-year plan of 635 million yen was 33.4%, also surpassing the four-year average of 21.1%.
In the most recent three-month period, from October to December (1Q), the operating profit margin improved from 8.5% in the same period last year to 10.5%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2022 | 1,563 | 145 | 145 | 99 | 29.2 | 43.3 | Feb 10, 2023 | J-GAAP |
Oct - Dec, 2023 | 1,648 | 140 | 139 | 89 | 27.2 | 50.7 | Feb 9, 2024 | J-GAAP |
Oct - Dec, 2024 | 2,013 | 212 | 212 | 132 | 40.6 | ー | Feb 10, 2025 | J-GAAP |
YoY | +22.1% | +51.4% | +52.5% | +48.3% | +49.4% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 3,418 | 275 | 274 | 180 | 55.0 | - | May 10, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | ー | ー | ー | ー | - | - | Nov 14, 2024 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep, 2023 | 6,486 | 697 | 701 | 438 | 132.4 | 25.50 | Nov 14, 2023 | J-GAAP |
Sep, 2024 | 7,165 | 631 | 629 | 404 | 123.1 | 26 | Nov 14, 2024 | J-GAAP |
Sep, 2025 Guidance | 8,606 | 635 | 635 | 404 | 130.6 | 27 | Nov 14, 2024 | J-GAAP |
YoY | +20.1% | +0.6% | +1.0% | 0.0% | +6.1% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 1,648 | 140 | 139 | 89 | 27.2 | 8.5 | Feb 9, 2024 | J-GAAP |
Jan - Mar, 2024 | 1,770 | 135 | 135 | 91 | 27.8 | 7.6 | May 10, 2024 | J-GAAP |
Apr - Jun, 2024 | 1,845 | 180 | 181 | 110 | 33.5 | 9.8 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 1,902 | 176 | 174 | 114 | 34.7 | 9.3 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 2,013 | 212 | 212 | 132 | 40.6 | 10.5 | Feb 10, 2025 | J-GAAP |
YoY | +22.1% | +51.4% | +52.5% | +48.3% | +49.4% |
Related Articles
TAZMO, Last Fiscal Year Ordinary Profit Revised Upward by 33%, Raises Record High Profit Forecast
KOBAYASHI PHARMA, 43% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
Immuno-Biological Lab, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5.2 times, Exceeds Full-Year Plan
Nippon Carbon, 2% Increase in Ordinary Profit for The Current Fiscal Year
NISSAN TOKYO SALES, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 9%
MINATO HOLDINGS , Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 49%
Maruichi Steel Tube, The Current Fiscal Year Net Income Revised Upward to an Unexpected 2% Increase
SAYLOR ADVERTISING, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Widens, Oct-Dec Ordinary Profit Decreases by 90%
SOLXYZ, 25% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 1 yen
WILL GROUP, Oct-Dec (3Q) Net Income Increases by 3.8 times